Community Trust & Investment Co. Makes New Investment in MetLife, Inc. (NYSE:MET)


Share on StockTwits

Community Trust & Investment Co. bought a new position in MetLife, Inc. (NYSE:MET) during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 7,546 shares of the financial services provider’s stock, valued at approximately $459,000.

Other hedge funds have also added to or reduced their stakes in the company. Sara Bay Financial bought a new stake in MetLife during the first quarter worth $169,000. Farmers & Merchants Trust Co of Chambersburg PA grew its position in shares of MetLife by 677.4% during the 1st quarter. Farmers & Merchants Trust Co of Chambersburg PA now owns 653 shares of the financial services provider’s stock valued at $40,000 after acquiring an additional 569 shares during the period. CVA Family Office LLC bought a new position in MetLife during the first quarter valued at $62,000. AdvisorNet Financial Inc lifted its position in shares of MetLife by 30.2% during the 1st quarter. AdvisorNet Financial Inc now owns 3,096 shares of the financial services provider’s stock valued at $188,000 after buying an additional 719 shares during the last quarter. Finally, FDx Advisors Inc. increased its holdings in MetLife by 21.8% in the 1st quarter. FDx Advisors Inc. now owns 30,957 shares of the financial services provider’s stock worth $1,882,000 after acquiring an additional 5,533 shares during the last quarter. 74.44% of the stock is owned by institutional investors.

In other news, CFO John D. Mccallion sold 7,456 shares of MetLife stock in a transaction dated Friday, February 5th. The stock was sold at an average price of $52.22, for a total value of $389,352.32. Following the transaction, the chief financial officer now owns 38,977 shares in the company, valued at $2,035,378.94. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. 0.07% of the stock is currently owned by company insiders.

MET stock traded down $0.43 during mid-day trading on Friday, hitting $62.30. 4,553,769 shares of the stock were exchanged, compared to its average volume of 5,739,009. The business has a fifty day moving average price of $60.47 and a 200 day moving average price of $49.79. MetLife, Inc. has a 12 month low of $29.18 and a 12 month high of $63.06. The company has a debt-to-equity ratio of 0.21, a current ratio of 0.15 and a quick ratio of 0.15. The stock has a market capitalization of $55.10 billion, a price-to-earnings ratio of 10.23, a PEG ratio of 1.98 and a beta of 1.35.

MetLife (NYSE:MET) last issued its earnings results on Wednesday, February 3rd. The financial services provider reported $2.03 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.53 by $0.50. The business had revenue of $20.58 billion during the quarter, compared to analyst estimates of $16.12 billion. MetLife had a return on equity of 8.17% and a net margin of 8.82%. MetLife’s revenue for the quarter was up 13.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.98 earnings per share. As a group, equities analysts forecast that MetLife, Inc. will post 5.65 EPS for the current fiscal year.

MET has been the topic of several recent research reports. JPMorgan Chase & Co. increased their target price on MetLife from $58.00 to $64.00 and gave the stock an “overweight” rating in a research report on Monday, April 5th. Royal Bank of Canada lifted their target price on MetLife from $57.00 to $66.00 in a report on Thursday, April 1st. Barclays upped their price target on MetLife from $65.00 to $69.00 and gave the company an “overweight” rating in a research report on Monday. They noted that the move was a valuation call. Argus boosted their price objective on shares of MetLife from $53.00 to $63.00 and gave the company a “buy” rating in a research note on Wednesday, February 17th. Finally, Citigroup raised their price target on shares of MetLife from $58.00 to $69.00 in a report on Wednesday, March 31st. Two equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus target price of $58.15.

MetLife Company Profile

MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.

See Also: How can you know how many shares are floating?

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.